The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Yang Meng, Nadine Hertel, John Ellis, Edith Morais, Helen Johnson, Zoe Philips, Neil Roskell, Andrew Walker, Dawn Lee
| Year of publication: |
November 2018
|
|---|---|
| Authors: | Meng, Yang ; Hertel, Nadine ; Ellis, John ; Morais, Edith ; Johnson, Helen ; Philips, Zoe ; Roskell, Neil ; Walker, Andrew ; Lee, Dawn |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 19.2018, 8, p. 1163-1172
|
| Subject: | Nivolumab | Cost-effectiveness | Economic evaluation | Advanced melanoma | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Gesundheitsökonomik | Health economics | Patienten | Patients | Kosten-Nutzen-Analyse | Cost-benefit analysis | Großbritannien | United Kingdom | Gesundheitsversorgung | Health care | Gesundheitskosten | Health care costs |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-018-0964-4 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10011948237